Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;
10.1016/j.aohep.2024.101544
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28:
Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;
10.1016/j.aohep.2021.100648